Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury (2023)

Kellum, J. A., Lameire, N., Aspelin, P., Barsoum, R. S., Burdmann, E. A., Goldstein, S. L., Herzog, C. A., Joannidis, M., Kribben, A., Levey, A. S., MacLeod, A. M., Mehta, R. L., Murray, P. T., Naicker, S., Opal, S. M., Schaefer, F., Schetz, M., & Uchino, S. (2012). Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements, 2(1), 1-138. https://doi.org/10.1038/kisup.2012.1

Kidney disease : Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. / Kellum, John A.; Lameire, Norbert; Aspelin, Peter et al.

In: Kidney International Supplements, Vol. 2, No. 1, 03.2012, p. 1-138.

Research output: Contribution to journal › Editorial › peer-review

Kellum, JA, Lameire, N, Aspelin, P, Barsoum, RS, Burdmann, EA, Goldstein, SL, Herzog, CA, Joannidis, M, Kribben, A, Levey, AS, MacLeod, AM, Mehta, RL, Murray, PT, Naicker, S, Opal, SM, Schaefer, F, Schetz, M & Uchino, S 2012, 'Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury', Kidney International Supplements, vol. 2, no. 1, pp. 1-138. https://doi.org/10.1038/kisup.2012.1

Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL et al. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements. 2012 Mar;2(1):1-138. doi: 10.1038/kisup.2012.1

Kellum, John A. ; Lameire, Norbert ; Aspelin, Peter et al. / Kidney disease : Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. In: Kidney International Supplements. 2012 ; Vol. 2, No. 1. pp. 1-138.

@article{aea06425fa1748bdbfb49d75c4eaf614,

title = "Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury",

abstract = "The 2011 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Acute Kidney Injury (AKI) aims to assist practitioners caring for adults and children at risk for or with AKI, including contrast-induced acute kidney injury (CI-AKI). Guideline development followed an explicit process of evidence review and appraisal. The guideline contains chapters on definition, risk assessment, evaluation, prevention, and treatment. Definition and staging of AKI are based on the Risk, Injury, Failure; Loss, End-Stage Renal Disease (RIFLE) and Acute Kidney Injury Network (AKIN) criteria and studies on risk relationships. The treatment chapters cover pharmacological approaches to prevent or treat AKI, and management of renal replacement for kidney failure from AKI. Guideline recommendations are based on systematic reviews of relevant trials. Appraisal of the quality of the evidence and the strength of recommendations followed the GRADE approach. Limitations of the evidence are discussed and specific suggestions are provided for future research.",

keywords = "Clinical Practice Guideline, KDIGO, acute kidney injury, contrast-induced nephropathy, evidence-based recommendation, renal replacement therapy",

author = "Kellum, {John A.} and Norbert Lameire and Peter Aspelin and Barsoum, {Rashad S.} and Burdmann, {Emmanuel A.} and Goldstein, {Stuart L.} and Herzog, {Charles A.} and Michael Joannidis and Andreas Kribben and Levey, {Andrew S.} and MacLeod, {Alison M.} and Mehta, {Ravindra L.} and Murray, {Patrick T.} and Saraladevi Naicker and Opal, {Steven M.} and Franz Schaefer and Miet Schetz and Shigehiko Uchino",

year = "2012",

month = mar,

doi = "10.1038/kisup.2012.1",

language = "English (US)",

volume = "2",

pages = "1--138",

journal = "Kidney International Supplements",

issn = "2157-1724",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Kidney disease

T2 - Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury

AU - Kellum, John A.

AU - Lameire, Norbert

AU - Aspelin, Peter

AU - Barsoum, Rashad S.

AU - Burdmann, Emmanuel A.

AU - Goldstein, Stuart L.

AU - Herzog, Charles A.

AU - Joannidis, Michael

AU - Kribben, Andreas

AU - Levey, Andrew S.

AU - MacLeod, Alison M.

AU - Mehta, Ravindra L.

AU - Murray, Patrick T.

AU - Naicker, Saraladevi

AU - Opal, Steven M.

AU - Schaefer, Franz

AU - Schetz, Miet

AU - Uchino, Shigehiko

PY - 2012/3

Y1 - 2012/3

N2 - The 2011 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Acute Kidney Injury (AKI) aims to assist practitioners caring for adults and children at risk for or with AKI, including contrast-induced acute kidney injury (CI-AKI). Guideline development followed an explicit process of evidence review and appraisal. The guideline contains chapters on definition, risk assessment, evaluation, prevention, and treatment. Definition and staging of AKI are based on the Risk, Injury, Failure; Loss, End-Stage Renal Disease (RIFLE) and Acute Kidney Injury Network (AKIN) criteria and studies on risk relationships. The treatment chapters cover pharmacological approaches to prevent or treat AKI, and management of renal replacement for kidney failure from AKI. Guideline recommendations are based on systematic reviews of relevant trials. Appraisal of the quality of the evidence and the strength of recommendations followed the GRADE approach. Limitations of the evidence are discussed and specific suggestions are provided for future research.

AB - The 2011 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Acute Kidney Injury (AKI) aims to assist practitioners caring for adults and children at risk for or with AKI, including contrast-induced acute kidney injury (CI-AKI). Guideline development followed an explicit process of evidence review and appraisal. The guideline contains chapters on definition, risk assessment, evaluation, prevention, and treatment. Definition and staging of AKI are based on the Risk, Injury, Failure; Loss, End-Stage Renal Disease (RIFLE) and Acute Kidney Injury Network (AKIN) criteria and studies on risk relationships. The treatment chapters cover pharmacological approaches to prevent or treat AKI, and management of renal replacement for kidney failure from AKI. Guideline recommendations are based on systematic reviews of relevant trials. Appraisal of the quality of the evidence and the strength of recommendations followed the GRADE approach. Limitations of the evidence are discussed and specific suggestions are provided for future research.

KW - Clinical Practice Guideline

KW - KDIGO

KW - acute kidney injury

KW - contrast-induced nephropathy

KW - evidence-based recommendation

KW - renal replacement therapy

UR - http://www.scopus.com/inward/record.url?scp=84884342549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884342549&partnerID=8YFLogxK

U2 - 10.1038/kisup.2012.1

DO - 10.1038/kisup.2012.1

M3 - Editorial

AN - SCOPUS:84884342549

VL - 2

SP - 1

EP - 138

JO - Kidney International Supplements

JF - Kidney International Supplements

SN - 2157-1724

IS - 1

ER -